Orbsen Awarded 6 Million Euros to Test Cell Therapy for Diabetic Kidney Disease

8 June 2015: TheJournal.ie: “NUI Galway spin-out company Orbsen Therapeutics used patented technology to discover the stromal cell therapy, which uses cells purified from healthy donor bone marrow. The four-year research project will see some 48 patients taking part in clinical trials in Galway, Belfast, Birmingham and Bergamo to test the treatment.

“The project, a collaboration between 11 European partners, will be led by Professor Timothy O’Brien, director of NUIG’s Regenerative Medicine Institute, who said, ‘We are confident that by harnessing the most modern approaches in stromal cell therapeutics there may well be a way to halt the progression of diabetic kidney disease using this therapy.'” Read the full story at TheJournal.ie.
2018-03-15T12:35:48+00:00 December 1st, 2015|